Retatrutide is in Phase 3 trials for type 2 diabetes (TRANSCEND-T2D program), obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease, chronic kidney disease in patients with type 2 diabetes, knee osteoarthritis, and cardiovascular outcomes [1][8][10][11]
Not long ago, managing appetite was mostly about willpower, strict dieting, or simply eating less. Today, the conversation is shifting toward the hormones that actually drive hunger and energy balance especially GLP-1
If GLP-1 helps communicate fullness and reduce appetite, GIP appears to play a larger role in how the body processes nutrients, responds to insulin, and manages energy after eating
Consequently, prescribing compounded Tirzepatide for weight loss now carries increased legal and regulatory risks for healthcare providers
Keep reading to learn more about how much semaglutide costs with and without insurance plus, tips for lowering the price of your prescription and alternative medications that may be worth discussing with your healthcare provider